63 results
6-K
EX-99.2
REPCF
Replicel Life Sciences Inc.
30 Nov 23
Condensed Consolidated Interim Financial Statements
1:05pm
The obligation to pay royalties of $16 million USD is classified as a financial liability and measured initially at its fair value and subsequently … were classified as liability. Management was required to make estimates to determine the fair value of the components of the preference share
6-K
EX-99.1
REPCF
Replicel Life Sciences Inc.
30 Nov 23
Condensed Consolidated Interim Financial Statements
1:05pm
at a future date, which is a derivative liability accounted for at FVTPL.
The obligation to pay royalties of $16 million USD is classified as a financial
6-K
EX-99.2
REPCF
Replicel Life Sciences Inc.
24 Oct 23
Condensed Consolidated Interim Financial Statements
11:10am
of $16 million USD is classified as a financial liability and measured initially at its fair value and subsequently at amortized cost. Management … redemption RepliCel preference shares were classified as liability. Management was required to make estimates to determine the fair value of the components
6-K
EX-99.1
REPCF
Replicel Life Sciences Inc.
24 Oct 23
Condensed Consolidated Interim Financial Statements
11:10am
at an agreed price at a future date, which is a derivative liability accounted for at FVTPL.
The obligation to pay royalties of $16 million USD is classified
6-K
EX-99.1
REPCF
Replicel Life Sciences Inc.
30 May 23
Condensed Consolidated Interim Financial Statements
5:40pm
of $16 million USD is classified as a financial liability and measured initially at its fair value and subsequently at amortized cost. Management
6-K
EX-99.2
4ftxk2erd30cltym1whf
30 May 23
Condensed Consolidated Interim Financial Statements
5:40pm
6-K
EX-99.2
00yrr08mmbfqif0ik94
29 Nov 22
Condensed Consolidated Interim Financial Statements
6:44pm
6-K
EX-99.1
p0m6z7pj
29 Nov 22
Condensed Consolidated Interim Financial Statements
6:44pm
20-F/A
64co ftza2upj9cjz
12 Sep 22
Annual report (foreign) (amended)
6:17pm
6-K
EX-99.2
7ll2vav8 cpcot3z2gt2
6 Sep 22
Condensed Consolidated Interim Financial Statements
12:42pm
6-K
EX-99.1
etnze5xqqq3a8qi8nan
6 Sep 22
Condensed Consolidated Interim Financial Statements
12:42pm
6-K
EX-99.4
4uz54j xeyavmp9
7 Jul 22
RepliCel Provides Update on Private Placement
3:36pm
6-K
EX-99.3
musbmf3apzm2j
7 Jul 22
RepliCel Provides Update on Private Placement
3:36pm
6-K
EX-99.2
xtv05j5hkkkqsp0d1spr
30 Nov 21
Condensed Consolidated Interim Financial Statements
1:50pm
6-K
EX-99.1
qkeygf96k2p3a0
30 Nov 21
Condensed Consolidated Interim Financial Statements
1:50pm
6-K
EX-99.1
lrnsv r2v
31 Aug 21
Condensed Consolidated Interim Financial Statements
1:45pm
6-K
EX-99.2
utn9 jh3msgurd
31 Aug 21
Condensed Consolidated Interim Financial Statements
1:45pm
6-K
EX-99.2
s36ztjyaizvym8
1 Jun 21
Condensed Consolidated Interim Financial Statements
3:57pm